Healthcare
Star Equity Holdings, Inc.(STRR)
Live Price
Offline$11.41
+2.98% today
1Y Change
+29.73%
Window
Jun 20, 2025 โ Jun 12, 2026
- Market Cap
- $40.00M
- Revenue Growth
- +222.6%
- EPS Growth
- +47.6%
- Dividend Yield
- 0.0%
Coverage: 246 bars ยท Jun 20, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Star Equity Holdings, Inc. (STRR) is a Healthcare stock with a market cap of $40.00M and listed on NASDAQ. The stock last traded around $11.41 and up 29.7% across the available one-year price window (Jun 20, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of +222.6%, EPS growth of +47.6%, a dividend yield of 0.0%. What stands out right now is revenue +222.6%, EPS +47.6%, free cash flow -11.5% with operating margin -3.1% and ROIC -5.0%. Valuation is more restrained than many high-expectation growth names at price/sales 0.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines STRR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+222.6% vs +7.6% peer median
Operating Margin
Below sector median
-3.1% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 12, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +222.6% and EPS at +47.6%, with operating margin around -3.1%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.4% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 12, 2026 | โ | -2.7% | +3.5% | +19.3% |
2026 Mar 17, 2026 | -171.4% | -1.0% | +1.9% | -0.9% |
2025 Nov 13, 2025 | -93.8% | +2.5% | -4.3% | +5.8% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
STRR
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
STRR Max Drawdown
-21.68%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for STRR and SPY.
Company Overview
Star Equity Holdings, Inc.
NASDAQ Global Select
Star Equity Holdings, Inc. provides healthcare solutions in the United States and internationally. It operates through four segments: Diagnostic Services, Diagnostic Imaging, Construction, and Investments. It offers imaging services primarily to cardiologists, internal medicine physicians, and family practice doctors; and imaging systems, including nuclear cardiac and general purpose nuclear imaging systems to physician offices and hospitals. The company also develops, sells, and maintains solid-state gamma cameras; and provides camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.
- Leadership
- Jeffrey E. Eberwein
- IPO Date
- Jun 10, 2004
- Employees
- 194
- Street Address
- 53 Forest Avenue
- Mailing
- Old Greenwich, CT, 06870
- Region
- Old Greenwich, CT, US
- Reporting Currency
- USD
- Investor Line
- 203 489 9500
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.2
- Price/Book
- 0.5
Growth
- Revenue
- +222.6%
- EPS
- +47.6%
- Free Cash Flow
- -11.5%
Profitability
- Gross Margin
- 43.0%
- Operating Margin
- -3.1%
- Net Margin
- -3.5%
- ROE
- -10.0%
- ROIC
- -5.0%
Balance Sheet
- Debt/Equity
- 0.40
- Current Ratio
- 2.10
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.